Global Hereditary Testing Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2022 –2029 |
 Market Size (Base Year) |
USD 1.90 Billion |
 Market Size (Forecast Year) |
USD 3.83 Billion |
 CAGR |
% |
| Major Markets Players |
>全球遗传检测市场，包括遗传性癌症检测（肺癌、乳腺癌、结直肠癌、宫颈癌、卵巢癌、前列腺癌、胃癌、黑色素瘤、肉瘤、子宫癌、胰腺癌等）、遗传性非癌症检测（基因检测、新生儿基因筛查、植入前基因诊断和筛查、无创产前检测（NIPT）和携带者筛查测试）– 行业趋势和预测到 2029 年。
遗传检测市场分析及规模
由于癌症和遗传疾病的发病率上升，以及人们对个性化治疗的了解和接受度增加，预计遗传检测市场将在未来几年大幅扩张。药物基因组学（通常称为药物基因检测）经常使用遗传检测。遗传检测方法的改进预计将加速市场扩张。
Data Bridge Market Research 分析，2021 年遗传检测市场规模为 19 亿美元，到 2029 年将飙升至 38.3 亿美元，预计在 2022 年至 2029 年的预测期内复合年增长率为 9.15%。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。
遗传检测市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制至 2019 - 2014） |
|
定量单位 |
收入（单位：十亿美元）、销量（单位：台）、定价（美元） |
|
涵盖的领域 |
遗传性癌症检测（肺癌、乳腺癌、结直肠癌、宫颈癌、卵巢癌、前列腺癌、胃癌、黑色素瘤、肉瘤、子宫癌、胰腺癌等）、遗传性非癌症检测（基因检测、新生儿基因筛查、植入前基因诊断和筛查、无创产前检测（NIPT）和携带者筛查测试） |
|
覆盖国家 |
北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲的其他地区。 |
|
涵盖的市场参与者 |
CENTOGENE N.V. (Germany), Ambry Genetics (U.S.), Myriad Genetics, Inc. (U.S.), NeoGenomics Laboratories (U.S.), Quest Diagnostics Incorporated (U.S.), PreventionGenetics (U.S.), Fulgent Genetics (U.S.), Invitae Corporation (U.S.), Medical Diagnostic Laboratories, L.L.C. (U.S.), Natera (U.S.), Caris Life Sciences (U.S.), LabSolutions (U.S.), Progenity Inc. (U.S.), ARUP Laboratories (U.S.) |
|
Market Opportunities |
|
Market Definition
In hereditary testing, particular inherited variations (variants) in a person's genes are changed. On the probability of contracting diseases, genetic variations might have negative, positive, neutral (no effect), or ambiguous effects. There is evidence that certain genes with harmful mutations enhance the likelihood of acquiring cancer. It is estimated that 5 to 10% of all malignancies are caused by these hereditary variations.
Hereditary Testing Market Dynamics
Drivers
- Increasing prevalence of hereditary cancer
Cancer is a genetic disorder produced due to definite changes in genes that administrate cell efficacy, mainly moving their growth and duplication. Hereditary genetic mutations are the reason of ~5–10% of all cancers. The detectives have related mutations in precise genes with added 50 hereditary cancer syndromes which effects entities in emerging certain cancers.
- Development in genomic technology
Breast cancer is one of the most collective cancers in the world affecting almost 12.5% of women during their lifetime and 5%–10% of these patients have a hereditary form. BRCA1 and BRCA2 genes are the two most mutual mutated genes, but additional genes connected with hereditary breast cancer are emerging. New developments in genomic skills have directed to parallel testing of multiple genes.
Opportunities
Mutation in the genes is one factor that impacts the early detection of hereditary cancer, increasing market growth. At the same time, efficacy and cost-effectiveness over traditional testing methods also drive market growth. Moreover, mounting demand for initial discovery and precise analysis is a feature that drives market growth.
Restraints/Challenges
The performance of hereditary multigene panel testing raises several issues, such as the measures that the patients have to meet to undertake the test and the patient’s clinical association, which will obstruct the market growth.
This hereditary testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the hereditary testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Hereditary Testing Market
Many of the industries across the world have been harmfully wedged over the last 18 months. This can be attributed to significant disturbances experienced by their respective industrialized and supply-chain processes as a result of various precautionary lockdowns and other restrictions governing establishments across the globe enforced. Furthermore, consumer demand has also subsequently reduced as persons are now more keen on eradicating non-essential expenses from their respective budgets. Most persons' general economic status has been severely affected by this outbreak. These aforementioned elements are predictable to burden the revenue trajectory of the global hereditary testing market over the forecast timeline.
Recent Development
- In June 2020, Invitae and ArcherDX announced Monday morning that the two genetic testing companies have agreed to syndicate in command to expand their footmark in the cancer genetics and precision oncology space.
Global Hereditary Testing Market Scope
The hereditary testing market is segmented on the basis of type, indication and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Multi Panel Test
- Single-site Genetic Test
Indication
- Breast Cancer
- Ovarian Cancer
- Colorectal Cancer
- Others
End-user
- Diagnostic Laboratory
- Hospitals
- Others
Hereditary Testing Market Regional Analysis/Insights
The hereditary testing market is analysed and market size insights and trends are provided by country, type, indication and end user as referenced above.
遗传检测市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。
北美市场占据主导地位，这得益于该地区一次性收入的增加、先进医疗保健基础设施的可用性以及基因检测的日益普及。
由于癌症病例的增加和医疗保健行业的发展，预计未来几年亚太地区和欧洲的癌症发病率将显著增长。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
医疗保健基础设施增长安装基础和新技术渗透
遗传检测市场还为您提供每个国家/地区资本设备医疗保健支出增长、遗传检测市场不同类型产品的安装基数、使用生命线曲线的技术的影响以及医疗保健监管情景的变化及其对遗传检测市场的影响的详细市场分析。数据涵盖 2010-2020 年的历史时期。
竞争格局和遗传检测市场份额分析
遗传检测市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对遗传检测市场的关注有关。
遗传检测市场的一些主要参与者包括：
- CENTOGENE NV （德国）
- Ambry Genetics（美国）
- Myriad Genetics, Inc.（美国）
- NeoGenomics 实验室（美国）
- Quest Diagnostics Incorporated（美国）
- PreventionGenetics（美国）
- Fulgent Genetics（美国）
- Invitae Corporation（美国）
- 医学诊断实验室有限公司（美国）
- Natera（美国）
- Caris Life Sciences（美国）
- LabSolutions（美国）
- Progenity Inc.（美国）
- ARUP 实验室（美国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
